Senior consulting executive directly partnering with key leaders throughout the biopharmaceutical industry to optimize global pricing, market access, and commercialization strategies. Expertise in oncology, rare disease, and cell and gene therapy, including early pipeline opportunity assessment and evidence strategy.Closely involved in all client engagements and part of a Senior Leadership Team overseeing operations and development of 50+ consultants across US, UK, and Switzerland offices.

Lecturer for MBA and Executive Education Programs focused on Global Health Policy, Pricing and Market Access.

Senior leader within the Global Pricing and Market Access practice across New York and London; partnering with global clients to address key business questions around pricing, reimbursement and payer engagement strategy.Proving strategic oversight of major global workstreams, while maintaining responsibility for business development and new account growth.

Head of Pharma/Biotech Global Market Access group in New York City, acquired from GfK in October 2018. Focused on partnering with clients to optimize global access and positioning prior to launch through pricing and reimbursement strategy, value-based trial design, payer value message development, and competitive and launch readiness.* Vice President, Market Access, GfK (Jan 2018-Oct 2018)* Principal Consultant, Market Access, GfK (Oct 2016-Dec 2018)

Managing and growing strong, sustained client relationships through complex project work and ongoing thought partnership around competitive readiness and access strategy. Closely involved in execution of both regional and global business development and growth objectives. Significant internal role in managing personal/professional development of colleagues.

Responsible for defining key alliance initiatives with leaders across Evolent's core operational domains, identifying external partners to support overall product development and commercialization strategy, and evaluating performance of ongoing third party relationships.

Provided research and analytic support for clients, specializing in the impact of comparative effectiveness research and quality improvement efforts on market access and commercial success